The homozygous P582S mutation in the oxygen-dependent degradation domain of HIF-1α is associated with increased risk for prostate cancer

Avi Orr-Urtreger*, Anat Bar-Shira, Haim Matzkin, Nicola J. Mabjeesh

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

BACKGROUND. The heterodimeric transcription factor HIF-1 (hypoxia-inducible factor 1), consisting of a critically regulated HIF-1α subunit and a constitutively expressed HIF-1β subunit, is a master regulator of genes involved in adaptation and survival under low-oxygen conditions. Increased levels of HIF-1 activity are associated with increased tumor aggressiveness, therapeutic resistance, and mortality. METHODS. We studied 402 prostate cancer patients for the presence of the 1772C > T (P582S) and 1790G > A (A588T) mutations within the oxygen-dependent domain of HIF-1α. RESULTS. Homozygosity for the P582S mutation was fourfold greater among prostate cancer patients compared to controls (OR = 4.10 [C.I. 95% 1.11 < OR < 17.87], P = 0.018). The existence of this mutation in prostate cancer patients was not associated with any of the clinical or pathological characteristics of the disease. No significant differences were found between the frequencies of A588T mutation in prostate cancer patients and controls. CONCLUSIONS. Our data suggest that homozygous HIF1A P582S mutation confers significant susceptibility to prostate cancer.

Original languageEnglish
Pages (from-to)8-13
Number of pages6
JournalProstate
Volume67
Issue number1
DOIs
StatePublished - Jan 2007

Keywords

  • Germline mutation
  • HIF-1α
  • Jews
  • Prostate cancer

Fingerprint

Dive into the research topics of 'The homozygous P582S mutation in the oxygen-dependent degradation domain of HIF-1α is associated with increased risk for prostate cancer'. Together they form a unique fingerprint.

Cite this